
- In today’s CEO Daily: Diane Brady talks to GoodRx CEO Wendy Barnes.
- The big story: Trump, Putin, and Zelensky headed for “Trilat”.
- The markets: Flat or down.
- Plus: All the news and watercooler chat from Fortune.
Good morning. I know several people on GLP-1 drugs. Some transformed their health; one used it to shed 10 pounds nobody thought she needed to lose. Such drugs have become the fastest-growing segment of drug spending, accounting for 10.5% of employers’ average pharmacy costs so far this year, vs. 8.9% in 2024. That’s up from 6.9% in 2023, when Americans spent $71.7 billion on such drugs. On average, employers pay between $8,000 and $10,000 per user each year for these drugs through healthcare plans.